Teligene Us
Clinical trials sponsored by Teligene Us, explained in plain language.
-
New hope for rare lung cancer mutations: targeted pill under study
Disease control Recruiting nowThis study tests a new oral drug, sutetinib maleate, in people with advanced non-small cell lung cancer that has uncommon EGFR mutations. The goal is to see if the drug can shrink tumors or slow cancer growth. About 66 adults with measurable tumors and good organ function will ta…
Phase: PHASE2 • Sponsor: Teligene US • Aim: Disease control
Last updated May 03, 2026 15:18 UTC
-
New pill targets rare gene fusion in Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called TL118 for people with advanced solid tumors that have a specific gene change (NTRK fusion). The goal is to see if the drug can shrink tumors or slow their growth. About 60 adults whose cancer has worsened after other treatments will take part.
Phase: PHASE2 • Sponsor: Teligene US • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC